The low-density lipoprotein receptorrelated protein (LRP) is a member of the LDL receptor gene family that binds several ligands, including tissue-type plasminogen activator (tPA). tPA is found in blood, where its primary function is as a thrombolytic enzyme, and in the central nervous system where it mediates events associated with cell death. Cerebral ischemia induces changes in the neurovascular unit (NVU) that result in brain edema. We investigated whether the interaction between tPA and LRP plays a role in the regulation of the permeability of the NVU during cerebral ischemia. We found that the ischemic insult induces shedding of LRP's ectodomain from perivascular astrocytes into the basement membrane. This event associates with the detachment of astrocytic end-feet processes and the formation of areas of perivascular edema. The shedding of LRP's ectodomain is significantly decreased in tPA deficient (tPA ؊/؊ ) mice, is increased by incubation with tPA, and is inhibited by the receptor-associated protein (RAP).
IntroductionThe low-density lipoprotein receptor-related protein (LRP) is a member of the LDL receptor gene family composed of a 515-kDa heavy chain noncovalently bound to an 85-kDa light chain containing a transmembrane and a cytoplasmic domain. 1 LRP mediates the internalization of apoE-enriched lipoprotein particles, 2 ␣-2-macroglobulin-protease complexes, 3 and several other ligands, including plasminogen activators, proteinase-inhibitor complexes, clotting factors, and the amyloid precursor protein (APP). 1 LRP has also been implicated in cellular signal transduction pathways 4 and neurotransmission. 5 Like other signaling receptors such as Notch 6 and APP, 7 LRP undergoes a ␥-secretase-likedependent cleavage of its cytoplasmic site with release of its intramembranous domain. 8 This process is preceded by shedding of the receptor's ectodomain which may increase substrate availability for the enzymes that are required for the cleavage of the intramembranous or cytosolic sites. 8,9 Tissue-type plasminogen activator (tPA) is a ligand for LRP, 10,11 on binding to LRP induces a transient tyrosine phosphorylation of its cytoplasmic domain, and induces increased synthesis of 13 Animal studies have demonstrated that following the onset of cerebral ischemia there is an increase in endogenous tPA activity within the ischemic tissue, [14][15][16] and that either genetic deficiency of tPA 14,17 or its inhibition with neuroserpin 15,18 are associated with neuronal survival and decrease in the volume of the ischemic lesion.The neurovascular unit (NVU) is a dynamic structure consisting of endothelial cells, the basal lamina, astrocytic end-feet processes, pericytes, and neurons. 19,20 One of the functions of the NVU is to form a barrier, known as the blood-brain barrier (BBB), that regulates the entry of selected molecules from the blood into the central nervous system (CNS). 21,22 During cerebral ischemia the permeability of the NVU increases, resulting in the development of cerebral edema, 23,24 which is a ...